Author's posts
Robot Wars: $60B Intuitive Surgical Dominated Its Market For 20 Years. Now Rivals Like Alphabet Are Moving In
Intuitive Surgical was a pioneer in operating room robots, dominating the market with its da Vinci surgical helpers. Rivals are now coming for the spoils, and CEO Gary Guthart has a plan to head them off.
Johnson & Johnson To Buy Auris Health, A Robotics Rival to Intuitive Surgical
Johnson & Johnson plans to spend over $5 billion to boost its robotics program.
30 Under 30 Europe Science & Healthcare: How A 29-Year-Old Went From A Shallot Farm To The C-Suite
Meet young innovators and disruptors of the 30 Under 30 Europe class of 2019 in science and healthcare.
From Launch To IPO In 13 Months: Gossamer Bio CEO Says She’s Running Company Of Her Dreams
Immunology-focused biotech startup Gossamer Bio has its market debut, with a lead drug candidate targeting moderate-to-severe asthma.
Cloud Unicorn: Health Catalyst Reaches $1 Billion Valuation Sifting Through Hospitals’ Data
A software platform that helps hospitals analyze all their data to solve big problems, like reducing the number of opioids that are prescribed, is now worth over $1 billion.
Healthcare Venture Capital Funding Is Off To A Record Start In 2019
Healthcare startups raised a record $2.6 billion last month, but will these kinds of rounds continue for much longer?
CEOs, Patients And Innovators: Videos From Inside The 2018 Forbes Healthcare Summit
Missed the 2018 Forbes Healthcare Summit? Want to see your favorite discussions again? Here’s a video roundup of all the panels from the conference.
Sequencing Startup 10x Genomics Hits Unicorn Status With $35 Million Fundraise
10x Genomics is now valued at more than $1 billion following its latest fundraise.
Sequencing Startup 10x Genomics Hits Unicorn Status With $35 Million Fundraise
10x Genomics is now valued at more than $1 billion following its latest fundraise.
Bristol-Myers Squibb And Celgene’s Big Winner? Los Angeles Billionaire Patrick Soon-Shiong
Patrick Soon-Shiong’s net worth is up as Celgene shares surge following acquisition news.
